Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China.
Beijing Qiaozhao Xinye Biology Science and Technology Company Co., Ltd, Beijing, China.
BMC Pregnancy Childbirth. 2024 Jun 6;24(1):407. doi: 10.1186/s12884-024-06577-x.
The optimal timing of performing ICSI on immature oocytes for POSEIDON patients is still unknown to get better early embryonic development outcomes. The purpose of this study was to implore the most appropriate time to carry out ICSI on in vitro maturation GV and MI oocytes for POSEIDON patients.
Two hundred thirty-nine immature oocytes from 163 POSEIDON patients were prospectively performed ICSI at different timings: P-ICSI (ICSI was performed on in vitro matured oocytes 4-6 h after the first polar body extrusion, N = 81), R-ICSI (ICSI was performed on in vitro matured oocytes less than 4 h after the first polar body extrusion, N = 80), and E-ICSI (ICSI was performed on in vitro matured oocytes the next day after oocytes retrieval, N = 78). Fertilization and embryonic development outcomes were collected and statistically analyzed. Mitochondria distribution of cytoplasm of in vitro matured oocytes with different time cultures after the first polar body (PB1) extrusion was stained.
Compared to the E-ICSI group, more day 3 embryos from P-ICSI became blastocysts after sequential culture though without statistical significance (OR = 3.71, 95% CI: 0.94-14.63, P = 0.061). Compared to the E-ICSI group, more embryos from both P-ICSI and R-ICSI groups were clinically used with statistical significance (OR = 5.67, 95% CI: 2.24-14.35, P = 0.000 for P-ICSI embryos; OR = 3.23, 95% CI: 1.23-8.45, P = 0.017 for R-ICSI embryos). Compared to the E-ICSI group, transferred embryos from P-ICSI and R-ICSI had a higher implantation rate though without statistical significance (35.3% for P-ICSI embryos; 9.1% or R-ICSI embryos and 0% for E-ICSI embryos, P = 0.050). Among the three group, there were most healthy babies delivered from the P-ICSI group (5, 1 and 0 for P-ICSI, R-ICSI and E-ICSI respectively). The mitochondria in the cytoplasm of in vitro matured oocytes with a less than 4 h and 4-6 h culture after PB1 extrusion presented semiperipheral and diffused distribution patterns, respectively.
Our results revealed P-ICSI (ICSI was performed on in vitro matured oocytes 4-6 h after the first polar body extrusion) provided the most efficient method to utilize the immaturation oocytes basing on embryos utilization and live birth outcome for low prognosis patients under the POSEIDON classification. The mitochondria distribution of the in vitro matured oocytes' cytoplasm from P-ICSI varied that from R-ICSI.
为了获得更好的早期胚胎发育结果,对于 POSEIDON 患者,进行卵胞浆内单精子注射(ICSI)的最佳不成熟卵母细胞时机仍不清楚。本研究的目的是探讨在 POSEIDON 患者中对体外成熟的GV 和 MI 卵母细胞进行最合适的 ICSI 时机。
前瞻性地对 163 名 POSEIDON 患者的 239 个不成熟卵母细胞在不同时间进行 ICSI:P-ICSI(ICSI 在第一次极体排出后 4-6 小时对体外成熟的卵母细胞进行,N=81)、R-ICSI(ICSI 在第一次极体排出后小于 4 小时对体外成熟的卵母细胞进行,N=80)和 E-ICSI(ICSI 在卵母细胞回收后第二天对体外成熟的卵母细胞进行,N=78)。收集受精和胚胎发育结果并进行统计学分析。染色体外成熟卵母细胞第一次极体(PB1)排出后不同时间培养的细胞质中线粒体分布。
与 E-ICSI 组相比,尽管差异无统计学意义,但 P-ICSI 组中更多的第 3 天胚胎发育为囊胚(OR=3.71,95%CI:0.94-14.63,P=0.061)。与 E-ICSI 组相比,P-ICSI 和 R-ICSI 组的胚胎均有更多的临床应用,差异具有统计学意义(OR=5.67,95%CI:2.24-14.35,P=0.000 用于 P-ICSI 胚胎;OR=3.23,95%CI:1.23-8.45,P=0.017 用于 R-ICSI 胚胎)。与 E-ICSI 组相比,P-ICSI 和 R-ICSI 组的移植胚胎着床率更高,但差异无统计学意义(P-ICSI 胚胎 35.3%;R-ICSI 胚胎 9.1%或 E-ICSI 胚胎 0%,P=0.050)。在这三组中,来自 P-ICSI 组的健康婴儿数量最多(5、1 和 0 分别用于 P-ICSI、R-ICSI 和 E-ICSI)。第一次极体排出后培养小于 4 小时和 4-6 小时的体外成熟卵母细胞的细胞质中线粒体呈现出半周边和弥散分布模式。
我们的结果表明,基于胚胎利用和活产结局,对于 POSEIDON 分类中预后不良的患者,P-ICSI(ICSI 在第一次极体排出后 4-6 小时对体外成熟的卵母细胞进行)是利用不成熟卵母细胞的最有效方法。来自 P-ICSI 的卵母细胞的细胞质中线粒体分布与 R-ICSI 不同。